BIOA
BIOA
NASDAQ · Pharmaceuticals

Bioage Labs Inc

$17.99
+0.17 (+0.95%)
As of May 10, 10:14 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 10 77%
Hold 3 23%
Sell 0 0%
Price Target
Analyst Price Target -27.0% upside
Low Target $9.99
Average Target $13.14
High Target $19.07
Current Price $17.99
Current
$17.99
Target
$13.14
$9.99 $13.14 avg $19.07
Scenario Analysis
Bear Case
$9.99
-44.5%
Low target
Base Case
$13.14
-27.0%
Avg target
Bull Case
$19.07
+6.0%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$24.00
-25.0% from high
52-Week Low
$3.67
+390.2% from low
Target vs 52W High
$13.14
-45.3% vs high
Next Earnings Report
May 12, 2026
Today
EPS Est: $-0.65
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%